List of Tables
Table 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Teduglutide
Table 4. Key Players of Linaclotide
Table 5. Key Players of Others
Table 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2015-2020)
Table 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2021-2026)
Table 12. Peptide Based Gastrointestinal Disorders Therapeutics Market Market Trends
Table 13. Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
Table 14. Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
Table 15. Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
Table 16. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players (2015-2020)
Table 18. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2019)
Table 19. Global Peptide Based Gastrointestinal Disorders Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Type (2015-2020)
Table 25. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2021-2026)
Table 26. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Application (2015-2020)
Table 27. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Application (2021-2026)
Table 29. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 31. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 33. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2015-2020)
Table 35. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 37. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2015-2020)
Table 41. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 42. China Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 43. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 44. China Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 45. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 46. China Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2015-2020)
Table 47. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 49. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2015-2020)
Table 53. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 55. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2015-2020)
Table 59. Takeda Company Details
Table 60. Takeda Business Overview
Table 61. Takeda Product
Table 62. Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (US$ Million)
Table 63. Takeda Recent Development
Table 64. Ironwood Pharmaceuticals Company Details
Table 65. Ironwood Pharmaceuticals Business Overview
Table 66. Ironwood Pharmaceuticals Product
Table 67. Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (US$ Million)
Table 68. Ironwood Pharmaceuticals Recent Development
Table 69. Astellas Pharma Company Details
Table 70. Astellas Pharma Business Overview
Table 71. Astellas Pharma Product
Table 72. Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (US$ Million)
Table 73. Astellas Pharma Recent Development
Table 74. Allergan Company Details
Table 75. Allergan Business Overview
Table 76. Allergan Product
Table 77. Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (US$ Million)
Table 78. Allergan Recent Development
Table 79. Takeda Pharmaceutical Company Details
Table 80. Takeda Pharmaceutical Business Overview
Table 81. Takeda Pharmaceutical Product
Table 82. Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (US$ Million)
Table 83. Takeda Pharmaceutical Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Teduglutide Features
Figure 3. Linaclotide Features
Figure 4. Others Features
Figure 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered
Figure 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2021-2026)
Figure 13. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players in 2019
Figure 14. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2019
Figure 16. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Takeda Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
Figure 44. Ironwood Pharmaceuticals Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
Figure 45. Astellas Pharma Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
Figure 46. Allergan Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
Figure 47. Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
